A Mubadala Investment Co.-backed healthcare company said it agreed to acquire kidney-care provider Diaverum, extending the Abu Dhabi sovereign-wealth fund’s bet on healthcare.
M42, a newly launched healthcare operator owned by Mubadala and a partner company, G42, is acquiring Diaverum from U.K.-based buyout firm Bridgepoint Group PLC. The deal value wasn’t disclosed. The Wall Street Journal earlier reported the transaction values the business at more than $2 billion including debt, according to people familiar with the matter.
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Already a subscriber? Sign In
